Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of ...

La thérapie d’association positive a déjà été testée contre les cauchemars, de nouvelles recherches démontrent aujourd’hui l'efficacité d'une nouvelle thérapie. Cet essai clinique randomisé, mené par ...

Net proceeds from the Offering will be used for (i) expanding the scale of directly-owned stores in the PRC; (ii) purchasing existing product patents to develop proprietary products; and (iii) ...

Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and reduction in the total number of authorized ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has closed its previously announced private placement for the purchase and sale of an aggregate of ...

Fleurieux-sur-l’Arbresle - France - le 27 décembre 2024 à 18h. Safe Group annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des Marchés Financiers son Rapport financier ...

For the fiscal year ended September 30, 2024, Outlook Therapeutics reported a net loss of $75.4 million, or $4.06 per basic and diluted share, compared to a net loss of $59.0 million, or $4.72 per ...

Vor Bio expects to use net proceeds from the PIPE to fund clinical and preclinical development of its pipeline candidates and for general corporate purposes. The PIPE is expected to close on December ...

Portable, Travel-Friendly Device That Includes Everything You Need For On-The-Go Red Light Therapy. All Neatly Packed Into A ...

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has ...

WEED Inc. is a global cannabis and hemp bioresearch company based in the USA, focused on the development and application of cannabis–derived compounds for the treatment of human and animal diseases, ...

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company’s commitment to advancing veterinary cancer care. The division is led by a team of experienced ...